BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Kalaris Therapeutics Inc.

Headquarters: Palo Alto, CA, United States
Year Founded: 2019
Status: Public
Industry Sector: HealthTechnology
CEO: Andrew Oxtoby, MBA
Number Of Employees: 6
Enterprise Value: $-69,907,092
PE Ratio: -0.29
Exchange/Ticker 1: NASDAQ:KLRS
Exchange/Ticker 2: N/A
Latest Market Cap: $65,084,396